Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies

References

• Peters TJ. All about albumin. San Diego: Academic Press/Elsevier Inc; 1996.
   Google Scholar
• Carballal S, Radi R, Kirk MC, Barnes S, Freeman BA, Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003;42:9906–9914.
   PubMed Web of Science ®Google Scholar
• Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008;582:1783–1787.
   PubMed Web of Science ®Google Scholar
• Rappaport SM, Li H, Grigoryan H, Funk WE, Williams ER. Adductomics: characterizing exposures to reactive electrophiles. Toxicol Lett 2011. [Epub ahead of print] PubMed PMID: 21501670.
   Google Scholar
• Li H, Grigoryan H, Funk WE, Lu SS, Rose S, Williams ER, Rappaport SM. Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring. Mol Cell Proteomics 2011;10:M110.004606.
   Google Scholar
• Aldini G, Gamberoni L, Orioli M, Beretta G, Regazzoni L, Maffei Facino R, Carini M. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J Mass Spectrom 2006;41: 1149–1161.
   PubMed Web of Science ®Google Scholar
• Aldini G, Vistoli G, Regazzoni L, Gamberoni L, Facino RM, Yamaguchi S, . Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species?Chem Res Toxicol 2008;21:824–835.
   PubMed Web of Science ®Google Scholar
• Torres MJ, Turell L, Botti H, Antmann L, Carballal S, Ferrer-Sueta G, . Modulation of the reactivity of the thiol of human serum albumin and its sulfenic derivative by fatty acids. Arch Biochem Biophys 2012;521:102–110.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001; 60:358–363.
   PubMed Web of Science ®Google Scholar
• Kadota K, Yui Y, Hattori R, Murohara Y, Kawai C. Decreased sulfhydryl groups of serum albumin in coronary artery disease. Jpn Circ J 1991;55:937–941.
   PubMedGoogle Scholar
• Oettl K, Stadlbauer V, Petter F, Greilberger J, Putz-Bankuti C, Hallström S, . Oxidative damage of albumin in advanced liver disease. Biochim Biophys Acta 2008;1782:469–473.
   PubMed Web of Science ®Google Scholar
• Lamprecht M, Oettl K, Schwaberger G, Hofmann P, Greilberger JF. Protein modification responds to exercise intensity and antioxidant supplementation. Med Sci Sports Exerc 2009;41:155–163.
   PubMed Web of Science ®Google Scholar
• Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995;1247:12–16.
   PubMed Web of Science ®Google Scholar
• Ogasawara Y, Namai T, Togawa T, Ishii K. Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible biomarker for oxidative stress. Biochem Biophys Res Commun 2006;340:353–358.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Chen H, Togawa T, DiBello PM, Majors AK, Büdy B, . Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine. J Biol Chem 2001; 276:30111–30117.
   PubMed Web of Science ®Google Scholar
• Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, . Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 2007;18:799–810.
   PubMed Web of Science ®Google Scholar
• Musante L, Bruschi M, Candiano G, Petretto A, Dimasi N, Del Boccio P, . Characterization of oxidation end product of plasma albumin ‘in vivo’. Biochem Biophys Res Commun 2006;349:668–673.
   PubMedGoogle Scholar
• Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 2009;22: 636–643.
   PubMed Web of Science ®Google Scholar
• Del Vecchio L, Locatelli F, Carini M. Oxidative stress in dialysis patients – what we now know about it, its clinical effects and potential treatment/prevention. Semin Dial 2011;24:56–64.
   PubMed Web of Science ®Google Scholar
• Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, . Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004;66:1988–1993.
   PubMed Web of Science ®Google Scholar
• Lim PS, Cheng YM, Yang SM. Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology (Carlton) 2007;12:18–24.
   PubMed Web of Science ®Google Scholar
• Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, Otagiri M. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 2005;28:973–980.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov O, Dawnay A. Mass spectrometric monitoring of albumin in uremia. Kidney Int 2000;58:2228–2234.
   PubMedGoogle Scholar
• Bruschi M, Petretto A, Candiano G, Musante L, Movilli E, Santucci L, . Determination of the oxido-redox status of plasma albumin in hemodialysis patients. J Chromatogr B Analyt Technol Biomed Life Sci 2008;864:29–37.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Thomas GW, Bar-Or R, Rael LT, Scarborough K, Rao N, Shimonkevitz R. Commercial human albumin preparations for clinical use are immunosuppressive in vitro. Crit Care Med 2006;34:1707–1712.
   PubMed Web of Science ®Google Scholar
• Kleinova M, Belgacem O, Pock K, Rizzi A, Buchacher A, Allmaier G. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry. Rapid Commun Mass Spectrom 2005;19:2965–2973.
   PubMedGoogle Scholar
• Beck JL, Ambahera S, Yong SR, Sheil MM, de Jersey J, Ralph SF. Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry. Anal Biochem 2004;325:326–336.
   PubMedGoogle Scholar
• Bar-Or D, Heyborne KD, Bar-Or R, Rael LT, Winkler JV, Navot D. Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat Diagn 2005;25:245–249.
   PubMed Web of Science ®Google Scholar
• Boisvert MR, Koski KG, Skinner CD. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal Chem 2010;82:1133–1137.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Carini M, Orioli M, Vistoli G, Ragazzoni L, Rossi R, . Protein carbonylation: 2,4-dinitrophenylhydrazine is a derivatizing agent of both aldehydes/ketones and sulfenic acids. Free Radic Biol Med 2009;46:1411–1419.
   PubMed Web of Science ®Google Scholar
• Rossi R, Giustarini D, Milzani A, Dalle-Donne I. Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med 2009; 13:3131–3140.
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112–S119.
   PubMed Web of Science ®Google Scholar
• Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E. German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238–248.
   PubMed Web of Science ®Google Scholar
• Heerspink HJ, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine MJ, . Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 2009;373:1009–1015.
   PubMed Web of Science ®Google Scholar
• Terawaki H, Era S, Nakayama M, Hosoya T. Decrease in reduced-form albumin among chronic kidney disease patients: new insights in cardiovascular complications. Ther Apher Dial 2011;15:156–160.
   PubMed Web of Science ®Google Scholar
• Terawaki H, Matsuyama Y, Matsuo N, Ogura M, Mitome J, Hamaguchi A, . A lower level of reduced albumin induces serious cardiovascular incidence among peritoneal dialysis patients. Clin Exp Nephrol 2012. [Epub ahead of print] PubMed PMID: 22358613.
   Google Scholar
• Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 2000;28:1685–1696.
   PubMed Web of Science ®Google Scholar
• Go YM, Halvey PJ, Hansen JM, Reed M, Pohl J, Jones DP. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol 2007;171:1670–1681.
   PubMed Web of Science ®Google Scholar
• Vindis C, Escargueil-Blanc I, Uchida K, Elbaz M, Salvayre R, Negre-Salvayre A. Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis. Redox Rep 2007;12:96–100.
   PubMed Web of Science ®Google Scholar
• Annangudi SP, Deng Y, Gu X, Zhang W, Crabb JW, Salomon RG. Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE. Chem Res Toxicol 2008;21:1384–1395.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 2005,49:1044–1049.
   PubMed Web of Science ®Google Scholar
• Yun MR, Im DS, Lee SJ, Woo JW, Hong KW, Bae SS, Kim CD. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation. Free Radic Biol Med 2008;45:177–183.
   PubMed Web of Science ®Google Scholar
• Soejima A, Matsuzawa N, Hayashi T, Kimura R, Ootsuka T, Fukuoka K, . Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif 2004;22:525–529.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Hasuike Y, Otaki Y, Hama Y, Nanami M, Miyagawa K, . Free cysteine is increased in plasma from hemodialysis patients. Kidney Int 2003;63:1137–1140.
   PubMedGoogle Scholar
• Jeong W, Park SJ, Chang T-S, Lee DY, Rhee SG. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. J Biol Chem 2006;281:14400–14407.
   PubMed Web of Science ®Google Scholar
• Woo HA, Jeong W, Chang TS, Park KJ, Park SJ, Yang JS, Rhee SG. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem 2005; 280:3125–3128.
   PubMed Web of Science ®Google Scholar
• Kawakami A, Kubota K, Yamada N, Tagami U, Takehana K, Sonaka I, . Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS J 2006; 273:3346–3357.
   Google Scholar
• Ogasawara Y, Mukai Y, Togawa T, Suzuki T, Tanabe S, Ishii K. Determination of plasma thiol bound to albumin using affinity chromatography and high-performance liquid chromatography with fluorescence detection: ratio of cysteinyl albumin as a possible biomarker of oxidative stress. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 845:157–163.
   PubMed Web of Science ®Google Scholar
• Lenton KJ, Therriault H, Cantin AM, Fülöp T, Payette H, Wagner JR. Direct correlation of glutathione and ascorbate and their dependence on age and season in human lymphocytes. Am J Clin Nutr 2000;71:1194–1200.
   PubMedGoogle Scholar
• Mecocci P, Polidori MC, Troiano L, Cherubini A, Cecchetti R, Pini G, . Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic Biol Med 2000;28:1243–1248.
   PubMed Web of Science ®Google Scholar
• Macmillan-Crow LA, Cruthirds DL. Manganese superoxide dismutase in disease. Free Radic Res 2001;34:325–336.
   PubMed Web of Science ®Google Scholar
• Jones DP, Mody VC, Carlson JL, Lynn MJ, Sternberg P Jr. Redox analysis of human plasma allows separation of prooxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 2002;33:1290–1300.
   PubMed Web of Science ®Google Scholar